January 2022: CART by Skylabs

Our Gadget of the Month empowers you to live your life to the full: The CART manufactured by Skylabs

Our Gadget of the Month empowers you to live your life to the full: The CART manufactured by Skylabs!

Field of Application

CART is a ring-type medical device that continuously monitors your heart health using photoplethysmography and electrocardiogram signals.

Unique features of CART include:

  • Continuous heart monitoring
  • Atrial Fibrillation detection with 99.6% Accuracy
  • Real-time measurements and analysis
  • Remote data access from your doctor
  • Simplicity and ease of use

The heart rate is measured continuously and the ECG measurement can be triggered at will.

Technological Background

An irregular pulse wave is measured automatically by monitoring the blood flow in the finger through the optical sensor. Monitored data is sent to the cloud to detect and analyze atrial fibrillation using Artificial Intelligence. The results are sent to the companion user app and physician platform. The CART system combines photoplethysmography (PPG) to measure heart rate (HR) and detect atrial fibrillation. The electrocardiogram (ECG) measurements which are triggered at will provide the doctor with additional information.

This unique combination of sensor technologies packed into the small form factor of a ring makes the CART our Innovation of the Month! If you would like to learn more about CART, you are lucky: Skylabs is partnering with WT | Wearable Technologies again at the WT | Show at MEDICA 2022! Come and visit us and get introduced to Skylabs!

Want to learn more about Skylabs directly? Visit their Website: https://skylabs.io/

Sam Draper
January 5, 2022

January 2022

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Global Wearables Boom as India Leads with 53% Growth

Global wearables surge by 13%(CAGR), India's market grows 53% in 2023.

Fraunhofer ISE Develops World's Most Efficient Solar Cell

Researchers used a new antireflection coating to develop this best four-junction solar cell to date.

Apple Study: Women Experience Abnormal Periods

Apple Women's Health Study found 16.4% of the women experienced abnormal periods.

Nanusens Surpasses £200,000 Funding Target, Nearing £350,000

Nanusens has surpassed its £200,000 (US$259,833) initial funding target.
Discover more